New Substituted Indazoles, Methods for the Production Thereof, Pharmaceutical Preparations That Contain Said New Substituted Indazoles, and Use of Said New Substituted Indazoles to Produce Drugs
Bayer Pharma Aktiengesellschaft
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application PCT/EP2015/077596, filed Nov 25, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,308,634 | New Substituted Indazoles, Methods for the Production Thereof, Pharmaceutical Preparations That Contain Said New Substituted Indazoles, and Use of Said New Substituted Indazoles to Produce Drugs In force · High confidence | Bayer Pharma Aktiengesellschaft | In force | High confidence | ||
| US 10,793,545 | Substituted Indazoles, Methods for the Production Thereof, Pharmaceutical Preparations That Contain Said New Substituted Indazoles, and Use of Said New Substituted Indazoles to Produce Drugs In force · High confidence | Bayer Pharma Aktiengesellschaft | In force | High confidence | ||
| US 12,006,303 | Substituted Indazoles, Methods for the Production Thereof, Pharmaceutical Preparations That Contain Said Substituted Indazoles, and Use of Said Substituted Indazoles to Produce Drugs In force · Medium confidence | Bayer Pharma Aktiengesellschaft | In force | Medium confidence | ||
| US 12,006,304 | Substituted Indazoles, Methods for the Production Thereof, Pharmaceutical Preparations That Contain Said Substituted Indazoles, and Use of Said Substituted Indazoles to Produce Drugs In force · Medium confidence | Bayer Pharma Aktiengesellschaft | In force | Medium confidence | ||
| US 12,559,473 | Substituted Indazoles, Methods for the Production Thereof, Pharmaceutical Preparations That Contain Said New Substituted Indazoles, and Use of Said New Substituted Indazoles to Produce Drugs In force · Low confidence | Bayer Pharma Aktiengesellschaft | In force | Low confidence | ||
| Application 17/009,553 | Substituted Indazoles, Methods for the Production Thereof, Pharmaceutical Preparations That Contain Said New Substituted Indazoles, and Use of Said New Substituted Indazoles to Produce Drugs Abandoned Abandoned Oct 17, 2022 | Bayer Pharma Aktiengesellschaft | Abandoned | Abandoned Oct 17, 2022 |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Bayer Pharma Aktiengesellschaft.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.